RespiraFibre uses a 9‑micrometre nanotechnology sensor to add continuous breathing waveform monitoring to routine oxygen-delivery and respiratory interfaces, helping teams notice meaningful change sooner within existing workflows.
Ultra-sensitive nanotechnology fibres embedded into oxygen-delivery devices for accurate, continuous respiratory monitoring.
Ultra-fine fibres (~1/10th the width of a hair) detect every breath without discomfort or workflow disruption.
A lightweight reusable node wirelessly transmits high-fidelity breathing data to secure hospital systems (e.g. EPIC).
Enables earlier detection of deterioration, with future expansion to classify cough, speech, and shortness of breath.
Disposable sensors with reusable modules — ultra-low cost, zero electronic waste, scalable globally.
Continuous monitoring allows earlier intervention, helping to reduce ICU admissions and improve patient outcomes.
Early detection of deterioration can lower average length of stay (LoS), freeing beds and reducing costs.
A three-step nanotechnology and Edge‑to‑Cloud architecture designed for high‑stakes clinical monitoring.
Our humidity‑responsive fibre is pre‑integrated into standard nasal cannulas and masks. No new wearables, no skin‑perfusion issues—just seamless sensing within existing routine workflows.
By sensing directly at the nose and mouth, we eliminate the motion noise that plagues SpO₂‑derived monitoring. The result is a clean, motion‑tolerant respiratory waveform with a high signal‑to‑noise ratio.
Real‑time data is processed through our Edge+Cloud architecture, applying predictive analytics to surface pattern changes and alerting staff via a centralized UI before clinical deterioration escalates.
"A valid, reliable and autonomous source of respiratory rate data would be enormously valuable"